Biopharma Venture Capital & the Inflation Reduction Act

The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in Medicare drug costs


Comment
Show comments Hide Comments


Related Articles